Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 3 |
2019 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions.
Genes (Basel). 2023 Jan 19;14(2):262. doi: 10.3390/genes14020262.
Genes (Basel). 2023.
PMID: 36833189
Free PMC article.
BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories.
Hovland HN, Al-Adhami R, Ariansen SL, Van Ghelue M, Sjursen W, Lima S, Bolstad M, Berger AH, Høberg-Vetti H, Knappskog P, Haukanes BI, Aukrust I, Ognedal E.
Hovland HN, et al. Among authors: ariansen sl.
Fam Cancer. 2022 Oct;21(4):389-398. doi: 10.1007/s10689-021-00286-6. Epub 2022 Jan 4.
Fam Cancer. 2022.
PMID: 34981296
Free PMC article.
Item in Clipboard
Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations.
Wangensteen T, Felde CN, Ahmed D, Mæhle L, Ariansen SL.
Wangensteen T, et al. Among authors: ariansen sl.
Hered Cancer Clin Pract. 2019 May 22;17:14. doi: 10.1186/s13053-019-0113-9. eCollection 2019.
Hered Cancer Clin Pract. 2019.
PMID: 31143303
Free PMC article.
Item in Clipboard
Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
Langerud J, Jarhelle E, Van Ghelue M, Ariansen SL, Iversen N.
Langerud J, et al. Among authors: ariansen sl.
Hum Genomics. 2018 Nov 20;12(1):51. doi: 10.1186/s40246-018-0183-1.
Hum Genomics. 2018.
PMID: 30458859
Free PMC article.
Item in Clipboard
BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer.
Norum J, Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Undlien DE, Schlichting E, Mæhle L.
Norum J, et al. Among authors: ariansen sl.
ESMO Open. 2018 Apr 13;3(3):e000328. doi: 10.1136/esmoopen-2018-000328. eCollection 2018.
ESMO Open. 2018.
PMID: 29682331
Free PMC article.
Item in Clipboard
BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.
Heramb C, Wangensteen T, Grindedal EM, Ariansen SL, Lothe S, Heimdal KR, Mæhle L.
Heramb C, et al. Among authors: ariansen sl.
Hered Cancer Clin Pract. 2018 Jan 10;16:3. doi: 10.1186/s13053-017-0085-6. eCollection 2018.
Hered Cancer Clin Pract. 2018.
PMID: 29339979
Free PMC article.
Item in Clipboard
Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
Grindedal EM, Heramb C, Karsrud I, Ariansen SL, Mæhle L, Undlien DE, Norum J, Schlichting E.
Grindedal EM, et al. Among authors: ariansen sl.
BMC Cancer. 2017 Jun 21;17(1):438. doi: 10.1186/s12885-017-3422-2.
BMC Cancer. 2017.
PMID: 28637432
Free PMC article.
Item in Clipboard
Cite
Cite